Login / Signup

Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.

Christian LabenzGerrit ToengesYvonne HuberMichael NagelJens U MarquardtJörn M SchattenbergPeter R GalleJoachim LabenzMarcus-Alexander Wörns
Published in: Alimentary pharmacology & therapeutics (2019)
IL-6 serum levels are closely linked to the development of overt hepatic encephalopathy in patients with liver cirrhosis.
Keyphrases
  • early onset
  • genome wide
  • gene expression
  • dna methylation